FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 150 filers reported holding FATE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,558,985 | -54.1% | 550,940 | +2.0% | 1.57% | -51.9% |
| Q3 2022 | $12,100,000 | -11.4% | 539,940 | -2.0% | 3.25% | -12.6% |
| Q2 2022 | $13,652,000 | -29.7% | 550,940 | +10.0% | 3.72% | -26.5% |
| Q1 2022 | $19,421,000 | -10.8% | 500,930 | +34.6% | 5.06% | -7.6% |
| Q4 2021 | $21,775,000 | +6.7% | 372,160 | +8.1% | 5.48% | +1.1% |
| Q3 2021 | $20,410,000 | -25.2% | 344,360 | +9.5% | 5.42% | -5.1% |
| Q2 2021 | $27,283,000 | +5.3% | 314,360 | 0.0% | 5.71% | -7.2% |
| Q1 2021 | $25,919,000 | -14.7% | 314,360 | -6.0% | 6.15% | -32.0% |
| Q4 2020 | $30,403,000 | +73.5% | 334,360 | -23.7% | 9.05% | +58.8% |
| Q3 2020 | $17,525,000 | +4.1% | 438,460 | -10.7% | 5.70% | +17.2% |
| Q2 2020 | $16,841,000 | +61.3% | 490,861 | +4.4% | 4.86% | +11.6% |
| Q1 2020 | $10,439,000 | +13.5% | 470,000 | 0.0% | 4.36% | +38.0% |
| Q4 2019 | $9,198,000 | +26.0% | 470,000 | 0.0% | 3.16% | +15.0% |
| Q3 2019 | $7,299,000 | +498.8% | 470,000 | +682.9% | 2.74% | +499.3% |
| Q2 2019 | $1,219,000 | +1131.3% | 60,031 | +197.3% | 0.46% | +502.6% |
| Q1 2015 | $99,000 | -66.7% | 20,190 | -65.8% | 0.08% | -67.7% |
| Q4 2014 | $297,000 | -23.3% | 59,110 | -22.2% | 0.24% | -39.7% |
| Q3 2014 | $387,000 | -19.2% | 75,930 | 0.0% | 0.39% | -14.1% |
| Q2 2014 | $479,000 | – | 75,930 | – | 0.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,073,190 | $26,599,000 | 26.59% |
| Polaris Venture Management Co. V, L.L.C. | 1,823,186 | $23,391,000 | 24.97% |
| Casdin Capital, LLC | 2,550,000 | $32,717,000 | 5.60% |
| Redmile Group, LLC | 10,359,666 | $132,915,000 | 5.34% |
| Aquilo Capital Management, LLC | 697,096 | $8,944,000 | 4.33% |
| Eversept Partners, LP | 165,000 | $2,116,950 | 1.15% |
| Artal Group S.A. | 2,150,000 | $27,585,000 | 1.02% |
| AlpInvest Partners B.V. | 26,925 | $345,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,654,865 | $21,232,000 | 0.85% |
| Lisanti Capital Growth, LLC | 142,760 | $1,832,000 | 0.74% |